Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 168

1.

Effect of US Food and Drug Administration-Approved Pediatric Labeling on Dispensing of Extended-Release Oxycodone in the Outpatient Retail Setting.

Xu J, Gill R, Cruz M, Staffa J, Lurie P.

JAMA Pediatr. 2016 Nov 1;170(11):1103-1104. doi: 10.1001/jamapediatrics.2016.3197. No abstract available.

PMID:
27612007
2.

Trends in the Nonmedical Use of OxyContin, United States, 2006-2013.

Jones CM, Muhuri PK, Lurie PG.

Clin J Pain. 2016 Aug 10. [Epub ahead of print]

PMID:
27513641
3.

Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013.

Jones CM, Lurie PG, Compton WM.

Am J Public Health. 2016 Apr;106(4):689-90. doi: 10.2105/AJPH.2016.303062.

PMID:
26890174
4.

Effect of US Drug Enforcement Administration's Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing.

Jones CM, Lurie PG, Throckmorton DC.

JAMA Intern Med. 2016 Mar;176(3):399-402. doi: 10.1001/jamainternmed.2015.7799. No abstract available.

PMID:
26809459
5.

US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access Programs.

Kim T, Lurie P, Pazdur R.

J Clin Oncol. 2015 Nov 20;33(33):3979-80. doi: 10.1200/JCO.2015.63.4139. No abstract available.

PMID:
26282656
6.

Comparison of content of FDA letters not approving applications for new drugs and associated public announcements from sponsors: cross sectional study.

Lurie P, Chahal HS, Sigelman DW, Stacy S, Sclar J, Ddamulira B.

BMJ. 2015 Jun 10;350:h2758. doi: 10.1136/bmj.h2758.

7.

Expanded access to investigational drugs.

Lurie P, Chan-Tack KM, Woodcock J.

N Engl J Med. 2015 Apr 9;372(15):1473. doi: 10.1056/NEJMc1501823#SA1. No abstract available.

PMID:
25853763
8.

Preventing prescription opioid abuse--reply.

Jones CM, Lurie P, Woodcock J.

JAMA. 2015 Mar 10;313(10):1060-1. doi: 10.1001/jama.2015.0524. No abstract available.

PMID:
25756451
9.

Addressing prescription opioid overdose: data support a comprehensive policy approach.

Jones CM, Lurie P, Woodcock J.

JAMA. 2014 Nov 5;312(17):1733-4. doi: 10.1001/jama.2014.13480. No abstract available.

PMID:
25275855
10.

Expanded access to opioid overdose intervention: research, practice, and policy needs.

Compton WM, Volkow ND, Throckmorton DC, Lurie P.

Ann Intern Med. 2013 Jan 1;158(1):65-6. doi: 10.7326/0003-4819-158-1-201301010-00013. No abstract available.

PMID:
23277902
11.

Management of opioid analgesic overdose.

Throckmorton DC, Compton WM, Lurie P.

N Engl J Med. 2012 Oct 4;367(14):1371; author reply 1372-3. doi: 10.1056/NEJMc1209707#SA2. No abstract available.

PMID:
23034041
12.

A plea for a balanced treatment of noncompaction.

Lurie PR.

Am J Cardiol. 2012 Jan 1;109(1):146. doi: 10.1016/j.amjcard.2011.09.011. No abstract available.

PMID:
22176755
13.

Left to their own devices: breakdowns in United States medical device premarket review.

Hines JZ, Lurie P, Yu E, Wolfe S.

PLoS Med. 2010 Jul 13;7(7):e1000280. doi: 10.1371/journal.pmed.1000280. Review. No abstract available.

14.

US public opinion regarding proposed limits on resident physician work hours.

Blum AB, Raiszadeh F, Shea S, Mermin D, Lurie P, Landrigan CP, Czeisler CA.

BMC Med. 2010 Jun 1;8:33. doi: 10.1186/1741-7015-8-33.

15.

Measles outbreak associated with an international youth sporting event in the United States, 2007.

Chen TH, Kutty P, Lowe LE, Hunt EA, Blostein J, Espinoza R, Dykewicz CA, Redd S, Rota JS, Rota PA, Lute JR, Lurie P, Nguyen MD, Moll M, Reef SE, Sinclair JR, Bellini WJ, Seward JF, Ostroff SM.

Pediatr Infect Dis J. 2010 Sep;29(9):794-800. doi: 10.1097/INF.0b013e3181dbaacf.

PMID:
20400927
16.

Changing concepts of endocardial fibroelastosis.

Lurie PR.

Cardiol Young. 2010 Apr;20(2):115-23. doi: 10.1017/S1047951110000181. Review.

PMID:
20346203
17.

Transcranial magnetic stimulation not proven effective.

Yu E, Lurie P.

Biol Psychiatry. 2010 Jan 15;67(2):e13; author reply e15-7. doi: 10.1016/j.biopsych.2009.03.026. No abstract available.

PMID:
19793580
18.

DTC advertising harms patients and should be tightly regulated.

Lurie P.

J Law Med Ethics. 2009 Fall;37(3):444-50, 396. doi: 10.1111/j.1748-720X.2009.00405.x.

PMID:
19723255
19.

Case series of liver failure associated with rosiglitazone and pioglitazone.

Floyd JS, Barbehenn E, Lurie P, Wolfe SM.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1238-43. doi: 10.1002/pds.1804.

PMID:
19623674
20.

Reply to Lisanby et al. Post hoc analysis does not establish effectiveness of rTMS for depression.

Hines JZ, Lurie P, Wolfe SM.

Neuropsychopharmacology. 2009 Jul;34(8):2053-4. doi: 10.1038/npp.2009.22. No abstract available.

Items per page

Supplemental Content

Support Center